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INTRODUCTION: More than 2 million 
people/year suffer a bone fracture in the UK1. 
Reconstruction of bone defects represents a major 
clinical challenge and is addressed using a number 
of medical devices. Although medical device 
compositions and applications may differ widely, 
all attract microorganisms and represent niches for 
medical device associated infections. For open 
fractures, the risk of infection can be 55%2. These 
infections are often resistant to many of the 
currently available antibiotics and represent a huge 
and growing financial and healthcare burden. The 
aim of this study was a fundamental understanding 
of how the presence of host defence peptides 
(HDPs)3 and/or RGD can influence the outcome of 
cell vs. bacterial viability and proliferation. 
METHODS: The antimicrobial activity of four 
HDPs; K5, K6, E6 and 1018, alone or in 
combination with RGD, was tested against three 
bacterial strains; Staphylococcus (S.) aureus, S. 
epidermidis and Pseudomonas aeruginosa, and 
their biofilms under both static and dynamic flow 
conditions using a commercially available 
microfluidic system, the BioFlux. Their 
performance was compared to Vancomycin, 
Polymyxin and Nisin, using a live/dead assay and 
luminescence.    
The cytocompatibility of the above HDPs, alone or 
in combination with RGD was tested using breast 
cancer cell lines 231 and 468, human G-292 
osteosarcoma cells, human antipose-derived stem 
cells (ADSCs, Lonza) and a MTT assay. 
The performance of HDPs and/or RGD was also 
tested in S. epidermidis –G-292 co-culture systems 
using the BioFlux. S. epidermidis was introduced 
after an overnight G-292 culture.  
RESULTS: The HDPs were effective against both 
Gram-positive and Gram-negative bacterial strains 
in the presence or not of RGD, while the RGD did 
not affect at all the bacteria viability. The E6 
performed better against bacterial suspensions 
while the other three HDPs performed better 
against biofilms that were established using the 
BioFlux system. The antibiotics were more 
effective against bacterial suspensions than the 
HDPs at low concentrations such as 8 µg/ml; 
however the HDPs, in contrast to the antibiotics, 
were effective against both Gram-positive and 
negative strains and their biofilms, and performed 
better than Nisin. 
The presence of HDPs at concentrations higher 
than 8 µg/ml significantly reduced the cell 
viability with the increase in HDPs concentration. 
The ADSCs were the most susceptible. The 
presence though of RGD at low concentrations in 
parallel to HDPs significantly increased the cell 
viability in comparison to HDPs alone. 
In the case of S. epidermidis – G-292 co-culture 
systems in the BioFlux, the presence of HDPs 
significantly enhanced the cell viability, in 
comparison to the co-culture system without 
treatment, while the bacterial viability was 
reduced. The parallel presence of HDPs/RGD 
further supported cell viability and proliferation 
without compromising the antimicrobial and 
antibiofilm performance of the HDPs.   
DISCUSSION & CONCLUSIONS: These 
results show promising signs for the use of RGD in 
combination with HDPs towards the preparation of 
antimicrobial materials that allow tissue 
integration. Orthopaedic implants would therefore 
be a great application for this kind of combined 
HDPs/RGD systems. 
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